Skip to main content
Caplight Logo









Superbranche

Superbranche

Private
StrasbourgHealthcare & Life Scienceshttps://www.superbranche.com/

Last Round

Series A

Dec 16, 2024

Total Funding Raised

$15.29M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Superbranche is a biotechnology company that develops innovative magnetic nanoparticle platforms for the diagnosis and treatment of solid cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Imaging, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

magnetic nanoparticlestheranosticsmagnetic hyperthermiaprecision medicineiron oxide nanoparticlesmedical imagingnanomedicinemagnetic particle imagingMPIMRI contrast agentsoncology biotechcell therapy monitoringGMP manufacturingsolid tumor treatmentdeeptech biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Superbranche Comparables

Compare Superbranche with similar companies based on industry and business-model similarity.

Superbranche comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NH TherAguix
82%
LodeSpin Labs
77%
MagForce AG
71%

Superbranche Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 16, 2024
SeedJan 1, 2020

Superbranche Investors

Notable investors and investment history

Superbranche investors
InvestorRounds
Alsace Business AngelsSeries A, Seed
Capital Grand EstSeries A
BpifranceSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 17, 2026

    Grew 17% QoQ from 18 to 21 employees.

  • Jun 20, 2026

    Monthly visitors grew 219% MoM, from 180 to 574.

Recent news

Latest coverage and updates

  • is_developingJun 29, 2026

    Superbranche is developing SUPERSPIO20 nanoparticles.

Superbranche Filings

Explore SEC and related filing metadata, where available.

Superbranche filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Superbranche's valuation, stock price, and market status.

Is Superbranche a public or private company?

Superbranche is a private company.

What is the current stock price of Superbranche?

Superbranche is a private company with no public stock price. No recent secondary market data is available.

How much is Superbranche worth (valuation)?

Valuation information for Superbranche is not publicly available.

Can I buy Superbranche stock?

Superbranche shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Superbranche's last funding round?

Superbranche's most recent funding round was Series A on December 16, 2024.

Who are the main investors in Superbranche?

Key investors in Superbranche include Capital Grand Est, Bpifrance.

Will Superbranche IPO soon?

No public IPO plans have been announced for Superbranche.

How can I track Superbranche secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Superbranche's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersStrasbourg
Employee Range15
Year Founded2019
Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?